J&J's (JNJ) Janssen Receives FDA Panel Backing for MDR-TB Drug Bedaquiline
Go back to J&J's (JNJ) Janssen Receives FDA Panel Backing for MDR-TB Drug Bedaquiline| Johnson & Johnson (NYSE: JNJ) | Delayed: 260.35 -1.73 (0.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $262.08 | 52 Week High | $126.07 | |||
| Open | $260.65 | 52 Week Low | $94.28 | |||
| Day High | $261.71 | P/E | 54.13 | |||
| Day Low | $259.16 | EPS | $4.81 | |||
| Volume | 4,998,067 | |||||

